ArticleTherapeutic advances in medical oncology2020

Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retrospective analysis.

Heejung Chae et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.